{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:29:50Z","timestamp":1786552190373,"version":"build-2736575974"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T00:00:00Z","timestamp":1487894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Non profit private German Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00702-016-1661-z","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T09:05:18Z","timestamp":1487927118000},"page":"775-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Glutamate, T cells and multiple sclerosis"],"prefix":"10.1007","volume":"124","author":[{"given":"Mia","family":"Levite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"1661_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/cdd.2010.79","volume":"18","author":"P Affaticati","year":"2011","unstructured":"Affaticati P, Mignen O, Jambou F, Potier MC, Klingel-Schmitt I, Degrouard J, Peineau S, Gouadon E, Collingridge GL, Liblau R, Capiod T, Cohen-Kaminsky S (2011) Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death Differ 18:99\u2013108","journal-title":"Cell Death Differ"},{"key":"1661_CR2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.24202","volume":"76","author":"CJ Azevedo","year":"2014","unstructured":"Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D (2014) In vivo evidence of glutamate toxicity in multiple sclerosis. Ann Neurol 76:269\u2013278","journal-title":"Ann Neurol"},{"key":"1661_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2004.09.019","volume":"324","author":"AA Boldyrev","year":"2004","unstructured":"Boldyrev AA, Kazey VI, Leinsoo TA, Mashkina AP, Tyulina OV, Johnson P, Tuneva JO, Chittur S, Carpenter DO (2004) Rodent lymphocytes express functionally active glutamate receptors. Biochem Biophys Res Commun 324:133\u2013139","journal-title":"Biochem Biophys Res Commun"},{"key":"1661_CR4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1471-4159.2005.03456.x","volume":"95","author":"AA Boldyrev","year":"2005","unstructured":"Boldyrev AA, Carpenter DO, Johnson P (2005) Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem 95:913\u2013918","journal-title":"J Neurochem"},{"key":"1661_CR5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-014-1181-7","volume":"121","author":"M Boyko","year":"2014","unstructured":"Boyko M, Gruenbaum SE, Gruenbaum BF, Shapira Y, Zlotnik A (2014) Brain to blood glutamate scavenging as a novel therapeutic modality: a review. J Neural Transm (Vienna) 121:971\u2013979","journal-title":"J Neural Transm (Vienna)"},{"key":"1661_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuint.2010.12.014","volume":"58","author":"AS Carvalho","year":"2011","unstructured":"Carvalho AS, Torres LB, Persike DS, Fernandes MJ, Amado D, Naffah-Mazzacoratti Mda G, Cavalheiro EA, da Silva AV (2011) Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats. Neurochem Int 58:385\u2013390","journal-title":"Neurochem Int"},{"key":"1661_CR7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1460-9568.2012.08165.x","volume":"35","author":"PK Chang","year":"2012","unstructured":"Chang PK, Verbich D, McKinney RA (2012) AMPA receptors as drug targets in neurological disease\u2013advantages, caveats, and future outlook. Eur J Neurosci 35:1908\u20131916","journal-title":"Eur J Neurosci"},{"key":"1661_CR8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/sj.bjp.0706746","volume":"148","author":"A Chiocchetti","year":"2006","unstructured":"Chiocchetti A, Miglio G, Mesturini R, Varsaldi F, Mocellin M, Orilieri E, Dianzani C, Fantozzi R, Dianzani U, Lombardi G (2006) Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol 148:760\u2013768","journal-title":"Br J Pharmacol"},{"key":"1661_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0006-8993(00)02752-9","volume":"879","author":"Z Chu","year":"2000","unstructured":"Chu Z, Hablitz JJ (2000) Quisqualate induces an inward current via mGluR activation in neocortical pyramidal neurons. Brain Res 879:88\u201392","journal-title":"Brain Res"},{"key":"1661_CR10","doi-asserted-by":"crossref","first-page":"14801","DOI":"10.1074\/jbc.M110557200","volume":"277","author":"CD Collard","year":"2002","unstructured":"Collard CD, Park KA, Montalto MC, Alapati S, Buras JA, Stahl GL, Colgan SP (2002) Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 277:14801\u201314811","journal-title":"J Biol Chem"},{"key":"1661_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1\u2013105","journal-title":"Prog Neurobiol"},{"key":"1661_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/rcmb.2003-0177OC","volume":"30","author":"KG Dickman","year":"2004","unstructured":"Dickman KG, Youssef JG, Mathew SM, Said SI (2004) Ionotropic glutamate receptors in lungs and airways: molecular basis for glutamate toxicity. Am J Respir Cell Mol Biol 30:139\u2013144","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1661_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1677\/joe.0.1560519","volume":"156","author":"JC Divino Filho","year":"1998","unstructured":"Divino Filho JC, Hazel SJ, Furst P, Bergstrom J, Hall K (1998) Glutamate concentration in plasma, erythrocyte and muscle in relation to plasma levels of insulin-like growth factor (IGF)-I, IGF binding protein-1 and insulin in patients on haemodialysis. J Endocrinol 156:519\u2013527","journal-title":"J Endocrinol"},{"key":"1661_CR14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF00417824","volume":"114","author":"W Droge","year":"1988","unstructured":"Droge W, Eck HP, Betzler M, Schlag P, Drings P, Ebert W (1988) Plasma glutamate concentration and lymphocyte activity. J Cancer Res Clin Oncol 114:124\u2013128","journal-title":"J Cancer Res Clin Oncol"},{"key":"1661_CR15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/aid.1993.9.807","volume":"9","author":"W Droge","year":"1993","unstructured":"Droge W, Murthy KK, Stahl-Hennig C, Hartung S, Plesker R, Rouse S, Peterhans E, Kinscherf R, Fischbach T, Eck HP (1993) Plasma amino acid dysregulation after lentiviral infection. AIDS Res Hum Retroviruses 9:807\u2013809","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1661_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/BF00391360","volume":"115","author":"HP Eck","year":"1989","unstructured":"Eck HP, Drings P, Droge W (1989a) Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Res Clin Oncol 115:571\u2013574","journal-title":"J Cancer Res Clin Oncol"},{"key":"1661_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/intimm\/1.4.367","volume":"1","author":"HP Eck","year":"1989","unstructured":"Eck HP, Frey H, Droge W (1989b) Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions. Int Immunol 1:367\u2013372","journal-title":"Int Immunol"},{"key":"1661_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-2999(91)90625-Z","volume":"198","author":"SL Erdo","year":"1991","unstructured":"Erdo SL, Schafer M (1991) Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 198:215\u2013217","journal-title":"Eur J Pharmacol"},{"key":"1661_CR19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.2183","volume":"16","author":"F Fallarino","year":"2010","unstructured":"Fallarino F, Volpi C, Fazio F, Notartomaso S, Vacca C, Busceti C, Bicciato S, Battaglia G, Bruno V, Puccetti P, Fioretti MC, Nicoletti F, Grohmann U, Di Marco R (2010) Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat Med 16:897\u2013902","journal-title":"Nat Med"},{"key":"1661_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2014.02.011","volume":"81","author":"F Fazio","year":"2014","unstructured":"Fazio F, Zappulla C, Notartomaso S, Busceti C, Bessede A, Scarselli P, Vacca C, Gargaro M, Volpi C, Allegrucci M, Lionetto L, Simmaco M, Belladonna ML, Nicoletti F, Fallarino F (2014) Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. Neuropharmacology 81:237\u2013243","journal-title":"Neuropharmacology"},{"key":"1661_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","volume":"147","author":"U Feger","year":"2007","unstructured":"Feger U, Luther C, Poeschel S, Melms A, Tolosa E, Wiendl H (2007) Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147:412\u2013418","journal-title":"Clin Exp Immunol"},{"key":"1661_CR22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.57.4.671","volume":"57","author":"C Ferrarese","year":"2001","unstructured":"Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57:671\u2013675","journal-title":"Neurology"},{"key":"1661_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-0173(84)90020-1","volume":"319","author":"AC Foster","year":"1984","unstructured":"Foster AC, Fagg GE (1984) Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors. Brain Res 319:103\u2013164","journal-title":"Brain Res"},{"key":"1661_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2015.05.277","volume":"210","author":"JM Gammon","year":"2015","unstructured":"Gammon JM, Tostanoski LH, Adapa AR, Chiu YC, Jewell CM (2015) Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity. J Control Release 210:169\u2013178","journal-title":"J Control Release"},{"key":"1661_CR25","volume-title":"Nerve-driven immunity: neurotransmitters and neuropeptides in the immune system","author":"Y Ganor","year":"2012","unstructured":"Ganor Y, Levite M (2012) Glutamate in the immune system: glutamate receptors in immune cells, potent effects, endogenous production and involvement in disease. In: Levite M (ed) Nerve-driven immunity: neurotransmitters and neuropeptides in the immune system. Springer, Vienna"},{"key":"1661_CR26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","volume":"121","author":"Y Ganor","year":"2014","unstructured":"Ganor Y, Levite M (2014) The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm 121:983\u20131006","journal-title":"J Neural Transm"},{"key":"1661_CR27","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","volume":"170","author":"Y Ganor","year":"2003","unstructured":"Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M (2003) Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 170:4362\u20134372","journal-title":"J Immunol"},{"key":"1661_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4049\/jimmunol.178.2.683","volume":"178","author":"Y Ganor","year":"2007","unstructured":"Ganor Y, Teichberg VI, Levite M (2007) TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine\/paracrine granzyme B-mediated proteolytic cleavage. J Immunol 178:683\u2013692","journal-title":"J Immunol"},{"key":"1661_CR29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/10428190902878448","volume":"50","author":"Y Ganor","year":"2009","unstructured":"Ganor Y, Grinberg I, Reis A, Cooper I, Goldstein RS, Levite M (2009) Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147\/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo. Leuk Lymphoma 50:985\u2013997","journal-title":"Leuk Lymphoma"},{"key":"1661_CR30","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4049\/jimmunol.180.6.3866","volume":"180","author":"SK Garg","year":"2008","unstructured":"Garg SK, Banerjee R, Kipnis J (2008) Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype. J Immunol 180:3866\u20133873","journal-title":"J Immunol"},{"key":"1661_CR31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11481-013-9436-x","volume":"8","author":"A Gentile","year":"2013","unstructured":"Gentile A, Rossi S, Studer V, Motta C, De Chiara V, Musella A, Sepman H, Fresegna D, Musumeci G, Grasselli G, Haji N, Weiss S, Hayardeny L, Mandolesi G, Centonze D (2013) Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 8:651\u2013663","journal-title":"J Neuroimmune Pharmacol"},{"key":"1661_CR32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/019262301317052486","volume":"29","author":"SS Gill","year":"2001","unstructured":"Gill SS, Pulido OM (2001) Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol Pathol 29:208\u2013223","journal-title":"Toxicol Pathol"},{"key":"1661_CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2003.01972.x","volume":"87","author":"M Gottlieb","year":"2003","unstructured":"Gottlieb M, Wang Y, Teichberg VI (2003) Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119\u2013126","journal-title":"J Neurochem"},{"key":"1661_CR34","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1152\/ajpendo.2000.278.1.E83","volume":"278","author":"TE Graham","year":"2000","unstructured":"Graham TE, Sgro V, Friars D, Gibala MJ (2000) Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol Endocrinol Metab 278:E83\u2013E89","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1661_CR35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1476-5381.2012.02178.x","volume":"168","author":"G Grasselli","year":"2013","unstructured":"Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, Usiello A et al (2013) Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. Br J Pharmacol 168:502\u2013517","journal-title":"Br J Pharmacol"},{"key":"1661_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-12-394587-7.00002-6","volume":"115","author":"KJ Gregory","year":"2013","unstructured":"Gregory KJ, Noetzel MJ, Niswender CM (2013) Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders. Prog Mol Biol Transl Sci 115:61\u2013121","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1661_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1749-6632.2003.tb07533.x","volume":"993","author":"AJ Groom","year":"2003","unstructured":"Groom AJ, Smith T, Turski L (2003) Multiple sclerosis and glutamate. Ann N Y Acad Sci 993:229\u2013275 (discussion 287\u2013288)","journal-title":"Ann N Y Acad Sci"},{"key":"1661_CR38","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","volume":"35","author":"J Haas","year":"2005","unstructured":"Haas J, Hug A, Viehover A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, Storch-Hagenlocher B, Krammer PH, Suri-Payer E, Wildemann B (2005) Reduced suppressive effect of CD4+ CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35:3343\u20133352","journal-title":"Eur J Immunol"},{"key":"1661_CR39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.179.2.1322","volume":"179","author":"J Haas","year":"2007","unstructured":"Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B (2007) Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 179:1322\u20131330","journal-title":"J Immunol"},{"key":"1661_CR40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-1136(199705)20:1<79::AID-GLIA8>3.0.CO;2-0","volume":"20","author":"H Hardin-Pouzet","year":"1997","unstructured":"Hardin-Pouzet H, Krakowski M, Bourbonniere L, Didier-Bazes M, Tran E, Owens T (1997) Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20:79\u201385","journal-title":"Glia"},{"key":"1661_CR41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0197-0186(00)00075-9","volume":"38","author":"E Hinoi","year":"2001","unstructured":"Hinoi E, Ogita K, Takeuchi Y, Ohashi H, Maruyama T, Yoneda Y (2001) Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues. Neurochem Int 38:277\u2013285","journal-title":"Neurochem Int"},{"key":"1661_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1033.2003.03907.x","volume":"271","author":"E Hinoi","year":"2004","unstructured":"Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y (2004) Glutamate signaling in peripheral tissues. Eur J Biochem 271:1\u201313","journal-title":"Eur J Biochem"},{"key":"1661_CR43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","volume":"17","author":"M Hollmann","year":"1994","unstructured":"Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31\u2013108","journal-title":"Annu Rev Neurosci"},{"key":"1661_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0301-0082(03)00122-9","volume":"70","author":"JE Huettner","year":"2003","unstructured":"Huettner JE (2003) Kainate receptors and synaptic transmission. Prog Neurobiol 70:387\u2013407","journal-title":"Prog Neurobiol"},{"issue":"Suppl 1","key":"1661_CR45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","volume":"12","author":"M Kaul","year":"2005","unstructured":"Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA (2005) HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12(Suppl 1):878\u2013892","journal-title":"Cell Death Differ"},{"key":"1661_CR46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"JN Kew","year":"2005","unstructured":"Kew JN, Kemp JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:4\u201329","journal-title":"Psychopharmacology"},{"key":"1661_CR47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8096653","volume":"260","author":"H Komuro","year":"1993","unstructured":"Komuro H, Rakic P (1993) Modulation of neuronal migration by NMDA receptors. Science 260:95\u201397","journal-title":"Science"},{"key":"1661_CR48","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1096\/fj.05-3748fje","volume":"19","author":"T Korn","year":"2005","unstructured":"Korn T, Magnus T, Jung S (2005) Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J 19:1878\u20131880","journal-title":"FASEB J"},{"key":"1661_CR49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-2478(97)00086-2","volume":"58","author":"IA Kostanyan","year":"1997","unstructured":"Kostanyan IA, Merkulova MI, Navolotskaya EV, Nurieva RI (1997) Study of interaction between L-glutamate and human blood lymphocytes. Immunol Lett 58:177\u2013180","journal-title":"Immunol Lett"},{"key":"1661_CR50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/sji.12147","volume":"79","author":"M Kostic","year":"2014","unstructured":"Kostic M, Dzopalic T, Zivanovic S, Zivkovic N, Cvetanovic A, Stojanovic I, Vojinovic S, Marjanovic G, Savic V, Colic M (2014) IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis. Scand J Immunol 79:181\u2013186","journal-title":"Scand J Immunol"},{"key":"1661_CR51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000204234","volume":"16","author":"E Kvaratskhelia","year":"2009","unstructured":"Kvaratskhelia E, Maisuradze E, Dabrundashvili NG, Natsvlishvili N, Zhuravliova E, Mikeladze DG (2009) N-Methyl-d-aspartate and sigma-ligands change the production of interleukins 8 and 10 in lymphocytes through modulation of the NMDA glutamate receptor. Neuroimmunomodulation 16:201\u2013207","journal-title":"Neuroimmunomodulation"},{"key":"1661_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clinph.2014.05.031","volume":"126","author":"D Landi","year":"2015","unstructured":"Landi D, Vollaro S, Pellegrino G, Mulas D, Ghazaryan A, Falato E, Pasqualetti P, Rossini PM, Filippi MM (2015) Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis. Clin Neurophysiol 126:165\u2013169","journal-title":"Clin Neurophysiol"},{"key":"1661_CR53","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.3390\/ijms130810041","volume":"13","author":"A Leibowitz","year":"2012","unstructured":"Leibowitz A, Boyko M, Shapira Y, Zlotnik A (2012) Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci 13:10041\u201310066","journal-title":"Int J Mol Sci"},{"key":"1661_CR54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coph.2005.08.004","volume":"6","author":"J Lerma","year":"2006","unstructured":"Lerma J (2006) Kainate receptor physiology. Curr Opin Pharmacol 6:89\u201397","journal-title":"Curr Opin Pharmacol"},{"key":"1661_CR55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00702-014-1250-y","volume":"121","author":"M Levite Teichberg","year":"2014","unstructured":"Levite Teichberg M, Riederer P (2014) Glutamate and Vivian Teichberg: a story about science, medicine, memory and love. J Neural Transm (Vienna) 121:793\u2013796","journal-title":"J Neural Transm (Vienna)"},{"key":"1661_CR56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJMcibr0902052","volume":"361","author":"F Li","year":"2009","unstructured":"Li F, Tsien JZ (2009) Memory and the NMDA receptors. N Engl J Med 361:302\u2013303","journal-title":"N Engl J Med"},{"key":"1661_CR57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/mmr.2013.1793","volume":"9","author":"Y Li","year":"2014","unstructured":"Li Y, Hou X, Qi Q, Wang L, Luo L, Yang S, Zhang Y, Miao Z, Zhang Y, Wang F, Wang H, Huang W, Wang Z, Shen Y, Wang Y (2014) Scavenging of blood glutamate for enhancing brain-to-blood glutamate efflux. Mol Med Rep 9:305\u2013310","journal-title":"Mol Med Rep"},{"key":"1661_CR58","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.bjp.0704134","volume":"133","author":"G Lombardi","year":"2001","unstructured":"Lombardi G, Dianzani C, Miglio G, Canonico PL, Fantozzi R (2001) Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol 133:936\u2013944","journal-title":"Br J Pharmacol"},{"key":"1661_CR59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(03)00038-7","volume":"340","author":"G Lombardi","year":"2003","unstructured":"Lombardi G, Miglio G, Canonico PL, Naldi P, Comi C, Monaco F (2003) Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients. Neurosci Lett 340:5\u20138","journal-title":"Neurosci Lett"},{"key":"1661_CR60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/jnc.13456","volume":"136","author":"D Luchtman","year":"2016","unstructured":"Luchtman D, Gollan R, Ellwardt E, Birkenstock J, Robohm K, Siffrin V, Zipp F (2016) In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity. J Neurochem 136:971\u2013980","journal-title":"J Neurochem"},{"key":"1661_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12311-014-0613-0","volume":"14","author":"G Mandolesi","year":"2015","unstructured":"Mandolesi G, Gentile A, Musella A, Centonze D (2015) IL-1beta dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis. Cerebellum 14:19\u201322","journal-title":"Cerebellum"},{"key":"1661_CR62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuint.2007.04.009","volume":"51","author":"AP Mashkina","year":"2007","unstructured":"Mashkina AP, Tyulina OV, Solovyova TI, Kovalenko EI, Kanevski LM, Johnson P, Boldyrev AA (2007) The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem Int 51:356\u2013360","journal-title":"Neurochem Int"},{"key":"1661_CR63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/349760a0","volume":"349","author":"M Masu","year":"1991","unstructured":"Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991) Sequence and expression of a metabotropic glutamate receptor. Nature 349:760\u2013765","journal-title":"Nature"},{"key":"1661_CR64","first-page":"97","volume":"468","author":"C Matute","year":"1999","unstructured":"Matute C, Domercq M, Fogarty DJ, Pascual de Zulueta M, Sanchez-Gomez MV (1999) On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS. Adv Exp Med Biol 468:97\u2013107","journal-title":"Adv Exp Med Biol"},{"key":"1661_CR65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0166-2236(00)01746-X","volume":"24","author":"C Matute","year":"2001","unstructured":"Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24:224\u2013230","journal-title":"Trends Neurosci"},{"key":"1661_CR66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1469-7580.2007.00733.x","volume":"210","author":"C Matute","year":"2007","unstructured":"Matute C, Alberdi E, Domercq M, Sanchez-Gomez MV, Perez-Samartin A, Rodriguez-Antiguedad A, Perez-Cerda F (2007) Excitotoxic damage to white matter. J Anat 210:693\u2013702","journal-title":"J Anat"},{"key":"1661_CR67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.conb.2005.05.004","volume":"15","author":"ML Mayer","year":"2005","unstructured":"Mayer ML (2005) Glutamate receptor ion channels. Curr Opin Neurobiol 15:282\u2013288","journal-title":"Curr Opin Neurobiol"},{"key":"1661_CR68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.conb.2011.02.001","volume":"21","author":"ML Mayer","year":"2011","unstructured":"Mayer ML (2011) Structure and mechanism of glutamate receptor ion channel assembly, activation and modulation. Curr Opin Neurobiol 21:283\u2013290","journal-title":"Curr Opin Neurobiol"},{"key":"1661_CR69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.physiol.66.050802.084104","volume":"66","author":"ML Mayer","year":"2004","unstructured":"Mayer ML, Armstrong N (2004) Structure and function of glutamate receptor ion channels. Annu Rev Physiol 66:161\u2013181","journal-title":"Annu Rev Physiol"},{"key":"1661_CR70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0301-0082(87)90011-6","volume":"28","author":"ML Mayer","year":"1987","unstructured":"Mayer ML, Westbrook GL (1987) The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28:197\u2013276","journal-title":"Prog Neurobiol"},{"key":"1661_CR71","first-page":"S14","volume":"44","author":"BS Meldrum","year":"1994","unstructured":"Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14\u2013S23","journal-title":"Neurology"},{"key":"1661_CR72","doi-asserted-by":"crossref","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","volume":"130","author":"BS Meldrum","year":"2000","unstructured":"Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130:1007S\u20131015S","journal-title":"J Nutr"},{"key":"1661_CR73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1742-2094-10-121","volume":"10","author":"N Melzer","year":"2013","unstructured":"Melzer N, Hicking G, Bittner S, Bobak N, Gobel K, Herrmann AM, Wiendl H, Meuth SG (2013) Excitotoxic neuronal cell death during an oligodendrocyte-directed CD8+ T cell attack in the CNS gray matter. J Neuroinflamm 10:121","journal-title":"J Neuroinflamm"},{"key":"1661_CR74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2011.00056","volume":"4","author":"CR Midgett","year":"2012","unstructured":"Midgett CR, Gill A, Madden DR (2012) Domain architecture of a calcium-permeable AMPA receptor in a ligand-free conformation. Front Mol Neurosci 4:56","journal-title":"Front Mol Neurosci"},{"key":"1661_CR75","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.bbrc.2005.10.164","volume":"338","author":"G Miglio","year":"2005","unstructured":"Miglio G, Varsaldi F, Lombardi G (2005) Human T lymphocytes express N-methyl-d-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun 338:1875\u20131883","journal-title":"Biochem Biophys Res Commun"},{"key":"1661_CR76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.pa.29.040189.002053","volume":"29","author":"DT Monaghan","year":"1989","unstructured":"Monaghan DT, Bridges RJ, Cotman CW (1989) The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365\u2013402","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1661_CR77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nrn916","volume":"3","author":"M Nedergaard","year":"2002","unstructured":"Nedergaard M, Takano T, Hansen AJ (2002) Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 3:748\u2013755","journal-title":"Nat Rev Neurosci"},{"key":"1661_CR78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-3639.2007.00101.x","volume":"18","author":"J Newcombe","year":"2008","unstructured":"Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52\u201361","journal-title":"Brain Pathol"},{"key":"1661_CR79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bj2390121","volume":"239","author":"P Newsholme","year":"1986","unstructured":"Newsholme P, Curi R, Gordon S, Newsholme EA (1986) Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 239:121\u2013125","journal-title":"Biochem J"},{"key":"1661_CR80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2015.11.004","volume":"5","author":"A Noori-Zadeh","year":"2016","unstructured":"Noori-Zadeh A, Mesbah-Namin SA, Bistoon-Beigloo S, Bakhtiyari S, Abbaszadeh HA, Darabi S, Rajabibazl M, Abdanipour A (2016) Regulatory T cell number in multiple sclerosis patients: a meta-analysis. Mult Scler Relat Disord 5:73\u201376","journal-title":"Mult Scler Relat Disord"},{"key":"1661_CR81","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0165-5728(02)00029-2","volume":"125","author":"M Ohgoh","year":"2002","unstructured":"Ohgoh M, Hanada T, Smith T, Hashimoto T, Ueno M, Yamanishi Y, Watanabe M, Nishizawa Y (2002) Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 125:170\u2013178","journal-title":"J Neuroimmunol"},{"key":"1661_CR82","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/00365518909091556","volume":"49","author":"G Ollenschlager","year":"1989","unstructured":"Ollenschlager G, Karner J, Karner-Hanusch J, Jansen S, Schindler J, Roth E (1989) Plasma glutamate\u2013a prognostic marker of cancer and of other immunodeficiency syndromes? Scand J Clin Lab Invest 49:773\u2013777","journal-title":"Scand J Clin Lab Invest"},{"key":"1661_CR83","doi-asserted-by":"crossref","first-page":"33352","DOI":"10.1074\/jbc.M401761200","volume":"279","author":"R Pacheco","year":"2004","unstructured":"Pacheco R, Ciruela F, Casado V, Mallol J, Gallart T, Lluis C, Franco R (2004) Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem 279:33352\u201333358","journal-title":"J Biol Chem"},{"key":"1661_CR84","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.4049\/jimmunol.177.10.6695","volume":"177","author":"R Pacheco","year":"2006","unstructured":"Pacheco R, Oliva H, Martinez-Navio JM, Climent N, Ciruela F, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R (2006) Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol 177:6695\u20136704","journal-title":"J Immunol"},{"key":"1661_CR85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2007.01.003","volume":"185","author":"R Pacheco","year":"2007","unstructured":"Pacheco R, Gallart T, Lluis C, Franco R (2007) Role of glutamate on T-cell mediated immunity. J Neuroimmunol 185:9\u201319","journal-title":"J Neuroimmunol"},{"key":"1661_CR86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","volume":"216","author":"R Pacheco","year":"2009","unstructured":"Pacheco R, Prado CE, Barrientos MJ, Bernales S (2009) Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 216:8\u201319","journal-title":"J Neuroimmunol"},{"key":"1661_CR87","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jneuroim.2008.01.011","volume":"195","author":"O Pampliega","year":"2008","unstructured":"Pampliega O, Domercq M, Villoslada P, Sepulcre J, Rodriguez-Antiguedad A, Matute C (2008) Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 195:194\u2013198","journal-title":"J Neuroimmunol"},{"key":"1661_CR88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.humimm.2016.01.016","volume":"77","author":"S Pankratz","year":"2016","unstructured":"Pankratz S, Ruck T, Meuth SG, Wiendl H (2016) CD4(+)HLA-G(+) regulatory T cells: molecular signature and pathophysiological relevance. Hum Immunol 77:727\u2013733","journal-title":"Hum Immunol"},{"key":"1661_CR89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.302.1.50","volume":"302","author":"C Paul","year":"2002","unstructured":"Paul C, Bolton C (2002) Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-d-aspartate receptor antagonist memantine. J Pharmacol Exp Ther 302:50\u201357","journal-title":"J Pharmacol Exp Ther"},{"key":"1661_CR90","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1038\/cddis.2013.507","volume":"5","author":"M Perez-Mato","year":"2014","unstructured":"Perez-Mato M, Ramos-Cabrer P, Sobrino T, Blanco M, Ruban A, Mirelman D, Menendez P, Castillo J, Campos F (2014) Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia. Cell Death Dis 5:e992","journal-title":"Cell Death Dis"},{"key":"1661_CR91","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","volume":"133","author":"D Piani","year":"1991","unstructured":"Piani D, Frei K, Do KQ, Cuenod M, Fontana A (1991) Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 133:159\u2013162","journal-title":"Neurosci Lett"},{"key":"1661_CR92","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/eji.1830220936","volume":"22","author":"D Piani","year":"1992","unstructured":"Piani D, Spranger M, Frei K, Schaffner A, Fontana A (1992) Macrophage-induced cytotoxicity of N-methyl-d-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 22:2429\u20132436","journal-title":"Eur J Immunol"},{"key":"1661_CR93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","volume":"6","author":"D Pitt","year":"2000","unstructured":"Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67\u201370","journal-title":"Nat Med"},{"key":"1661_CR94","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","volume":"173","author":"SR Platt","year":"2007","unstructured":"Platt SR (2007) The role of glutamate in central nervous system health and disease\u2014a review. Vet J 173:278\u2013286","journal-title":"Vet J"},{"key":"1661_CR95","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/mol.67.3.","volume":"67","author":"C Poulopoulou","year":"2005","unstructured":"Poulopoulou C, Markakis I, Davaki P, Nikolaou C, Poulopoulos A, Raptis E, Vassilopoulos D (2005) Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate. Mol Pharmacol 67:856\u2013867","journal-title":"Mol Pharmacol"},{"key":"1661_CR96","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/art.23446","volume":"58","author":"C Poulopoulou","year":"2008","unstructured":"Poulopoulou C, Papadopoulou-Daifoti Z, Hatzimanolis A, Fragiadaki K, Polissidis A, Anderzanova E, Davaki P, Katsiari CG, Sfikakis PP (2008) Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus. Arthritis Rheum 58:1445\u20131450","journal-title":"Arthritis Rheum"},{"key":"1661_CR97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/jcan.2002.125148","volume":"16","author":"JD Reynolds","year":"2002","unstructured":"Reynolds JD, Amory DW, Grocott HP, White WD, Newman MF (2002) Change in plasma glutamate concentration during cardiac surgery is a poor predictor of cognitive outcome. J Cardiothorac Vasc Anesth 16:431\u2013436","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1661_CR98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1078\/0065-1281-00688","volume":"105","author":"R Rezzani","year":"2003","unstructured":"Rezzani R, Corsetti G, Rodella L, Angoscini P, Lonati C, Bianchi R (2003) Cyclosporine\u2014A treatment inhibits the expression of metabotropic glutamate receptors in rat thymus. Acta Histochem 105:81\u201387","journal-title":"Acta Histochem"},{"key":"1661_CR99","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s10637-012-9794-x","volume":"30","author":"A Ruban","year":"2012","unstructured":"Ruban A, Berkutzki T, Cooper I, Mohar B, Teichberg VI (2012) Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Invest New Drugs 30:2226\u20132235","journal-title":"Invest New Drugs"},{"key":"1661_CR100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jcbfm.2013.186","volume":"34","author":"A Ruban","year":"2014","unstructured":"Ruban A, Mohar B, Jona G, Teichberg VI (2014) Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication. J Cereb Blood Flow Metab 34:221\u2013227","journal-title":"J Cereb Blood Flow Metab"},{"key":"1661_CR101","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.3390\/ijms16023226","volume":"16","author":"A Ruban","year":"2015","unstructured":"Ruban A, Biton IE, Markovich A, Mirelman D (2015) MRS of brain metabolite levels demonstrates the ability of scavenging of excess brain glutamate to protect against nerve agent induced seizures. Int J Mol Sci 16:3226\u20133236","journal-title":"Int J Mol Sci"},{"key":"1661_CR102","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","volume":"60","author":"P Sarchielli","year":"2003","unstructured":"Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 60:1082\u20131088","journal-title":"Arch Neurol"},{"key":"1661_CR103","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2007.05.021","volume":"188","author":"P Sarchielli","year":"2007","unstructured":"Sarchielli P, Di Filippo M, Candeliere A, Chiasserini D, Mattioni A, Tenaglia S, Bonucci M, Calabresi P (2007) Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol 188:146\u2013158","journal-title":"J Neuroimmunol"},{"key":"1661_CR104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/MN:24:1-3:107","volume":"24","author":"R Sattler","year":"2001","unstructured":"Sattler R, Tymianski M (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24:107\u2013129","journal-title":"Mol Neurobiol"},{"key":"1661_CR105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00702-014-1242-y","volume":"121","author":"S Saussez","year":"2014","unstructured":"Saussez S, Laumbacher B, Chantrain G, Rodriguez A, Gu S, Wank R, Levite M (2014) Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains. J Neural Transm 121:1007\u20131027","journal-title":"J Neural Transm"},{"key":"1661_CR106","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/71548","volume":"6","author":"T Smith","year":"2000","unstructured":"Smith T, Groom A, Zhu B, Turski L (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6:62\u201366","journal-title":"Nat Med"},{"key":"1661_CR107","first-page":"57","volume":"85","author":"T Spencer","year":"2001","unstructured":"Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T (2001) Tourette disorder and ADHD. Adv Neurol 85:57\u201377","journal-title":"Adv Neurol"},{"key":"1661_CR108","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-009-0613-1","volume":"132","author":"A Stepulak","year":"2009","unstructured":"Stepulak A, Luksch H, Gebhardt C, Uckermann O, Marzahn J, Sifringer M, Rzeski W, Staufner C, Brocke KS, Turski L, Ikonomidou C (2009) Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 132:435\u2013445","journal-title":"Histochem Cell Biol"},{"key":"1661_CR109","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00702-014-1182-6","volume":"121","author":"A Stepulak","year":"2014","unstructured":"Stepulak A, Rola R, Polberg K, Ikonomidou C (2014) Glutamate and its receptors in cancer. J Neural Transm 121:933\u2013944","journal-title":"J Neural Transm"},{"key":"1661_CR110","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00702-014-1188-0","volume":"121","author":"IR Stojanovic","year":"2014","unstructured":"Stojanovic IR, Kostic M, Ljubisavljevic S (2014) The role of glutamate and its receptors in multiple sclerosis. J Neural Transm 121:945\u2013955","journal-title":"J Neural Transm"},{"key":"1661_CR111","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(00)00269-1","volume":"109","author":"M Storto","year":"2000","unstructured":"Storto M, de Grazia U, Battaglia G, Felli MP, Maroder M, Gulino A, Ragona G, Nicoletti F, Screpanti I, Frati L, Calogero A (2000) Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J Neuroimmunol 109:112\u2013120","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"1661_CR112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2010.11.014","volume":"233","author":"JL Sturgill","year":"2011","unstructured":"Sturgill JL, Mathews J, Scherle P, Conrad DH (2011) Glutamate signaling through the kainate receptor enhances human immunoglobulin production. J Neuroimmunol 233(1\u20132):80\u201389","journal-title":"J Neuroimmunol"},{"key":"1661_CR113","doi-asserted-by":"crossref","first-page":"186068","DOI":"10.1155\/2013\/186068","volume":"2013","author":"G Sulkowski","year":"2013","unstructured":"Sulkowski G, Dabrowska-Bouta B, Struzynska L (2013) Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors. Biomed Res Int 2013:186068","journal-title":"Biomed Res Int"},{"key":"1661_CR114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0896-6273(92)90118-W","volume":"8","author":"Y Tanabe","year":"1992","unstructured":"Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S (1992) A family of metabotropic glutamate receptors. Neuron 8:169\u2013179","journal-title":"Neuron"},{"key":"1661_CR115","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/jcbfm.2011.46","volume":"31","author":"VI Teichberg","year":"2011","unstructured":"Teichberg VI (2011) GOT to rid the body of excess glutamate. J Cereb Blood Flow Metab 31:1376\u20131377","journal-title":"J Cereb Blood Flow Metab"},{"key":"1661_CR116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroscience.2008.02.075","volume":"158","author":"VI Teichberg","year":"2009","unstructured":"Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301\u2013308","journal-title":"Neuroscience"},{"key":"1661_CR117","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2005.06.017","volume":"21","author":"A Vallejo-Illarramendi","year":"2006","unstructured":"Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21:154\u2013164","journal-title":"Neurobiol Dis"},{"key":"1661_CR118","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/nen.0b013e31812571b0","volume":"66","author":"M Vercellino","year":"2007","unstructured":"Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P (2007) Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 66:732\u2013739","journal-title":"J Neuropathol Exp Neurol"},{"key":"1661_CR119","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971\u2013979","journal-title":"J Exp Med"},{"key":"1661_CR120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.1077","volume":"50","author":"P Werner","year":"2001","unstructured":"Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50:169\u2013180","journal-title":"Ann Neurol"},{"key":"1661_CR121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.tins.2004.04.005","volume":"27","author":"LP Wollmuth","year":"2004","unstructured":"Wollmuth LP, Sobolevsky AI (2004) Structure and gating of the glutamate receptor ion channel. Trends Neurosci 27:321\u2013328","journal-title":"Trends Neurosci"},{"key":"1661_CR122","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jnc.12263","volume":"125","author":"L Ye","year":"2013","unstructured":"Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, Qian G, Zheng JC (2013) IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem 125:897\u2013908","journal-title":"J Neurochem"},{"key":"1661_CR123","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2014.10.009","volume":"20","author":"S Zhu","year":"2015","unstructured":"Zhu S, Paoletti P (2015) Allosteric modulators of NMDA receptors: multiple sites and mechanisms. Curr Opin Pharmacol 20:14\u201323","journal-title":"Curr Opin Pharmacol"},{"key":"1661_CR124","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2006.08.021","volume":"203","author":"A Zlotnik","year":"2007","unstructured":"Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI (2007) Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203:213\u2013220","journal-title":"Exp Neurol"},{"key":"1661_CR125","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11064-007-9548-x","volume":"33","author":"A Zlotnik","year":"2008","unstructured":"Zlotnik A, Gurevich B, Cherniavsky E, Tkachov S, Matuzani-Ruban A, Leon A, Shapira Y, Teichberg VI (2008) The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res 33:1044\u20131050","journal-title":"Neurochem Res"},{"key":"1661_CR126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/ANA.0b013e3181a2bf0b","volume":"21","author":"A Zlotnik","year":"2009","unstructured":"Zlotnik A, Gruenbaum SE, Artru AA, Rozet I, Dubilet M, Tkachov S, Brotfain E, Klin Y, Shapira Y, Teichberg VI (2009) The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate. J Neurosurg Anesthesiol 21:235\u2013241","journal-title":"J Neurosurg Anesthesiol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-016-1661-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T02:13:21Z","timestamp":1568859201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-016-1661-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,24]]},"references-count":126,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s00702-016-1661-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,24]]}}}